Market Research Logo

Blood Pressure Disorders Drug Development Pipeline Review, 2018

Blood Pressure Disorders Drug Development Pipeline Review, 2018

Summary


Hypertension, also referred to as high blood pressure, is a condition in which the arteries have persistently elevated blood pressure. Many factors can affect blood pressure, including hormone levels, water and salt levels in the body and the condition of the kidneys, nervous system, and blood vessels.

Most people with high blood pressure have no signs or symptoms, even if blood pressure readings reach dangerously high levels. Although a few people with early-stage high blood pressure may have dull headaches, dizzy spells or a few more nosebleeds than normal, these signs and symptoms typically do not occur until high blood pressure has reached a severe stage. There are 253 products in development for this indication.

PAH is a type of high blood pressure that occurs in the right side of the heart and in the arteries that supply blood to the lungs. Symptoms include chest pain, fatigue, passing out suddenly, and swelling of the legs (edema). There are 92 products in development for this indication.

Low blood pressure, or hypotension, occurs when blood pressure during and after each heartbeat is much lower than usual. This means the heart, brain, and other parts of the body do not get enough blood. Symptoms include blurred vision, dizziness, confusion, sleeplessness and weakness. Pipeline activity is much lower for hypotension than for hypertension or PAH with only seven products in development for this indication.

Molecular targets acted on by products in development for blood pressure disorders include angiotensin receptors, tyrosine protein kinases and phosphodiesterases. Companies operating in this pipeline space include Gmax Biopharm, Actelion Pharmaceuticals and Theravance Biopharma.

This report “Blood Pressure Disorders Drug Development Pipeline Review, 2018” provides an overview of the pipeline landscape for blood pressure disorders. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for hypertension, pulmonary arterial hypertension (PAH) and hypotension, and features dormant and discontinued products.

Scope

  • Which companies are the most active within the pipeline for blood pressure disorders?
  • Which pharmaceutical approaches are most prominent at each stage of the pipeline and within each indication?
  • To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
  • What are the most important R&D milestones and data publications to have happened within this field?
Reasons to buy
  • Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
  • Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
  • Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
  • Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration


  • GBI Research Report Guidance
  • Executive Summary
  • Introduction
    • Blood Pressure Disorder Report Coverage
    • Hypertension – Overview
    • Hypotension – Overview
    • Pulmonary Arterial Hypertension – Overview
  • Therapeutics Development
    • Hypertension
      • Pipeline Overview
        • Table Figure 1: Number of Products under Development for Hypertension
        • Table Number of Products under Development for Hypertension
      • Pipeline by Companies
        • Table Figure 2: Number of Products under Development by Companies Hypertension
        • Table Number of Products under Development by Companies Hypertension
      • Pipeline by Universities/Institutes
        • Table Figure 3: Number of Products under Development by Universities/Institutes Hypertension
        • Table Number of Products under Development by Universities/Institutes Hypertension
      • Products under Development by Companies
        • Table Products under Development by Companies Hypertension
      • Products under Development by Universities/Institutes
        • Table Products under Development by Universities/Institutes Hypertension
    • Hypotension
      • Pipeline Overview
        • Table Figure 4: Number of Products under Development for Hypotension
        • Table Number of Products under Development for Hypotension
      • Pipeline by Companies
        • Table Figure 5: Number of Products under Development by Companies Hypotension
        • Table Number of Products under Development by Companies Hypotension
      • Products under Development by Companies
        • Table Products under Development by Companies Hypotension
    • Pulmonary Arterial Hypertension
      • Pipeline Overview
        • Table Figure 6: Number of Products under Development for Pulmonary Arterial Hypertension
        • Table Number of Products under Development for Pulmonary Arterial Hypertension
      • Pipeline by Companies
        • Table Figure 7: Number of Products under Development by Companies Pulmonary Arterial Hypertension
        • Table Number of Products under Development by Companies Pulmonary Arterial Hypertension
      • Pipeline by Universities/Institutes
        • Table Figure 8: Number of Products under Development by Universities/Institutes Pulmonary Arterial Hypertension
        • Table Number of Products under Development by Universities/Institutes Pulmonary Arterial Hypertension
      • Products under Development by Companies
        • Table Products under Development by Companies Pulmonary Arterial Hypertension
      • Products under Development by Universities/Institutes
        • Table Products under Development by Universities/Institutes Pulmonary Arterial Hypertension
  • Therapeutics Assessment
    • Hypertension
      • Assessment by Target
        • Table Figure 9: Number of Products by Top 10 Targets Hypertension
        • Table Figure 10: Number of Products by Stage and Top 10 Targets Hypertension
        • Table Number of Products by Stage and Target Hypertension
      • Assessment by Mechanism of Action
        • Table Figure 11: Number of Products by Top 10 Mechanism of Actions Hypertension
        • Table Figure 12: Number of Products by Stage and Top 10 Mechanism of Actions Hypertension
        • Table Number of Products by Stage and Mechanism of Action Hypertension
      • Assessment by Route of Administration
        • Table Figure 13: Number of Products by Top 10 Routes of Administration Hypertension
        • Table Figure 14: Number of Products by Stage and Top 10 Routes of Administration Hypertension
        • Table Number of Products by Stage and Route of Administration Hypertension
      • Assessment by Molecule Type
        • Table Figure 15: Number of Products by Top 10 Molecule Types Hypertension
        • Table Figure 16: Number of Products by Stage and Top 10 Molecule Types Hypertension
        • Table Number of Products by Stage and Molecule Type Hypertension
    • Hypotension
      • Assessment by Target
        • Table Figure 17: Number of Products by Targets Hypotension
        • Table Figure 18: Number of Products by Stage and Targets Hypotension
        • Table Number of Products by Stage and Target Hypotension
      • Assessment by Mechanism of Action
        • Table Figure 19: Number of Products by Mechanism of Actions Hypotension
        • Table Figure 20: Number of Products by Stage and Mechanism of Actions Hypotension
        • Table Number of Products by Stage and Mechanism of Action Hypotension
      • Assessment by Route of Administration
        • Table Figure 21: Number of Products by Routes of Administration Hypotension
        • Table Figure 22: Number of Products by Stage and Routes of Administration Hypotension
        • Table Number of Products by Stage and Route of Administration Hypotension
      • Assessment by Molecule Type
        • Table Figure 23: Number of Products by Molecule Types Hypotension
        • Table Figure 24: Number of Products by Stage and Molecule Types Hypotension
        • Table Number of Products by Stage and Molecule Type Hypotension
    • Pulmonary Arterial Hypertension
      • Assessment by Target
        • Table Figure 25: Number of Products by Top 10 Targets Pulmonary Arterial Hypertension
        • Table Figure 26: Number of Products by Stage and Top 10 Targets Pulmonary Arterial Hypertension
        • Table Number of Products by Stage and Target Pulmonary Arterial Hypertension
      • Assessment by Mechanism of Action
        • Table Figure 27: Number of Products by Top 10 Mechanism of Actions Pulmonary Arterial Hypertension
        • Table Figure 28: Number of Products by Stage and Top 10 Mechanism of Actions Pulmonary Arterial Hypertension
        • Table Number of Products by Stage and Mechanism of Action Pulmonary Arterial Hypertension
      • Assessment by Route of Administration
        • Table Figure 29: Number of Products by Routes of Administration Pulmonary Arterial Hypertension
        • Table Figure 30: Number of Products by Stage and Routes of Administration Pulmonary Arterial Hypertension
        • Table Number of Products by Stage and Route of Administration Pulmonary Arterial Hypertension
      • Assessment by Molecule Type
        • Table Figure 31: Number of Products by Top 10 Molecule Types Pulmonary Arterial Hypertension
        • Table Figure 32: Number of Products by Stage and Top 10 Molecule Types Pulmonary Arterial Hypertension
        • Table Number of Products by Stage and Molecule Type Pulmonary Arterial Hypertension
  • Companies Involved in Therapeutics Development
    • Hypertension
      • A1M Pharma AB
        • Table Hypertension – Pipeline by A1M Pharma AB
      • Acceleron Pharma Inc
        • Table Hypertension – Pipeline by Acceleron Pharma Inc
      • Ache Laboratorios Farmaceuticos SA
        • Table Hypertension – Pipeline by Ache Laboratorios Farmaceuticos SA
      • Actelion Pharmaceuticals Ltd
        • Table Hypertension – Pipeline by Actelion Pharmaceuticals Ltd
      • Aerogen Ltd
        • Table Hypertension – Pipeline by Aerogen Ltd
      • Anavex Life Sciences Corp
        • Table Hypertension – Pipeline by Anavex Life Sciences Corp
      • AnGes Inc
        • Table Hypertension – Pipeline by AnGes Inc
      • Arena Pharmaceuticals Inc
        • Table Hypertension – Pipeline by Arena Pharmaceuticals Inc
      • Ascendia Pharmaceuticals LLC
        • Table Hypertension – Pipeline by Ascendia Pharmaceuticals LLC
      • Ascendis Pharma A/S
        • Table Hypertension – Pipeline by Ascendis Pharma A/S
      • AVEO Pharmaceuticals Inc
        • Table Hypertension – Pipeline by AVEO Pharmaceuticals Inc
      • Bayer AG
        • Table Hypertension – Pipeline by Bayer AG
      • Bial - Portela & Ca SA
        • Table Hypertension – Pipeline by Bial - Portela & Ca SA
      • Bioblue Technologies Inc
        • Table Hypertension – Pipeline by Bioblue Technologies Inc
      • Biogen Inc
        • Table Hypertension – Pipeline by Biogen Inc
      • Biolab Farmaceutica Ltda
        • Table Hypertension – Pipeline by Biolab Farmaceutica Ltda
      • BioRestorative Therapies Inc
        • Table Hypertension – Pipeline by BioRestorative Therapies Inc
      • Boryung Pharmaceutical Co Ltd
        • Table Hypertension – Pipeline by Boryung Pharmaceutical Co Ltd
      • Bristol-Myers Squibb Co
        • Table Hypertension – Pipeline by Bristol-Myers Squibb Co
      • Camurus AB
        • Table Hypertension – Pipeline by Camurus AB
      • Capricor Therapeutics Inc
        • Table Hypertension – Pipeline by Capricor Therapeutics Inc
      • Celsion Corp
        • Table Hypertension – Pipeline by Celsion Corp
      • Celtaxsys Inc
        • Table Hypertension – Pipeline by Celtaxsys Inc
      • Chiesi Farmaceutici SpA
        • Table Hypertension – Pipeline by Chiesi Farmaceutici SpA
      • Chong Kun Dang Pharmaceutical Corp
        • Table Hypertension – Pipeline by Chong Kun Dang Pharmaceutical Corp
      • Chugai Pharmaceutical Co Ltd
        • Table Hypertension – Pipeline by Chugai Pharmaceutical Co Ltd
      • CJ HealthCare Corp
        • Table Hypertension – Pipeline by CJ HealthCare Corp
      • Complexa Inc
        • Table Hypertension – Pipeline by Complexa Inc
      • Corion Biotech Srl
        • Table Hypertension – Pipeline by Corion Biotech Srl
      • Cumberland Pharmaceuticals Inc
        • Table Hypertension – Pipeline by Cumberland Pharmaceuticals Inc
      • D. Western Therapeutics Institute Inc
        • Table Hypertension – Pipeline by D. Western Therapeutics Institute Inc
      • Daewon Pharm Co Ltd
        • Table Hypertension – Pipeline by Daewon Pharm Co Ltd
      • Daewoong Co Ltd
        • Table Hypertension – Pipeline by Daewoong Co Ltd
      • Daewoong Pharmaceutical Co Ltd
        • Table Hypertension – Pipeline by Daewoong Pharmaceutical Co Ltd
      • Daiichi Sankyo Co Ltd
        • Table Hypertension – Pipeline by Daiichi Sankyo Co Ltd
      • Denovo Biopharma LLC
        • Table Hypertension – Pipeline by Denovo Biopharma LLC
      • Eli Lilly and Co
        • Table Hypertension – Pipeline by Eli Lilly and Co
      • Esperion Therapeutics Inc
        • Table Hypertension – Pipeline by Esperion Therapeutics Inc
      • FunPep Co Ltd
        • Table Hypertension – Pipeline by FunPep Co Ltd
      • Galectin Therapeutics Inc
        • Table Hypertension – Pipeline by Galectin Therapeutics Inc
      • Gemphire Therapeutics Inc
        • Table Hypertension – Pipeline by Gemphire Therapeutics Inc
      • Gilead Sciences Inc
        • Table Hypertension – Pipeline by Gilead Sciences Inc
      • GlaxoSmithKline Plc
        • Table Hypertension – Pipeline by GlaxoSmithKline Plc
      • H. Lundbeck AS
        • Table Hypertension – Pipeline by H. Lundbeck AS
      • HanAll Biopharma Co Ltd
        • Table Hypertension – Pipeline by HanAll Biopharma Co Ltd
      • Hanmi Pharmaceuticals Co Ltd
        • Table Hypertension – Pipeline by Hanmi Pharmaceuticals Co Ltd
      • Idorsia Pharmaceutical Ltd
        • Table Hypertension – Pipeline by Idorsia Pharmaceutical Ltd
      • Ildong Pharmaceutical Co Ltd
        • Table Hypertension – Pipeline by Ildong Pharmaceutical Co Ltd
      • Innopharmax Inc
        • Table Hypertension – Pipeline by Innopharmax Inc
      • Insmed Inc
        • Table Hypertension – Pipeline by Insmed Inc
      • Insys Therapeutics Inc
        • Table Hypertension – Pipeline by Insys Therapeutics Inc
      • Ionis Pharmaceuticals Inc
        • Table Hypertension – Pipeline by Ionis Pharmaceuticals Inc
      • Japan Tobacco Inc
        • Table Hypertension – Pipeline by Japan Tobacco Inc
      • Jeil Pharmaceutical Co Ltd
        • Table Hypertension – Pipeline by Jeil Pharmaceutical Co Ltd
      • Johnson & Johnson
        • Table Hypertension – Pipeline by Johnson & Johnson
      • KBP BioSciences Co Ltd
        • Table Hypertension – Pipeline by KBP BioSciences Co Ltd
      • Leading BioSciences Inc
        • Table Hypertension – Pipeline by Leading BioSciences Inc
      • Lee's Pharmaceutical Holdings Ltd
        • Table Hypertension – Pipeline by Lee's Pharmaceutical Holdings Ltd
      • Les Laboratoires Servier SAS
        • Table Hypertension – Pipeline by Les Laboratoires Servier SAS
      • LG Chem Ltd
        • Table Hypertension – Pipeline by LG Chem Ltd
      • LinXis BV
        • Table Hypertension – Pipeline by LinXis BV
      • Liquidia Technologies Inc
        • Table Hypertension – Pipeline by Liquidia Technologies Inc
      • MannKind Corp
        • Table Hypertension – Pipeline by MannKind Corp
      • Marina Biotech Inc
        • Table Hypertension – Pipeline by Marina Biotech Inc
      • Merck & Co Inc
        • Table Hypertension – Pipeline by Merck & Co Inc
      • Mezzion Pharma Co Ltd
        • Table Hypertension – Pipeline by Mezzion Pharma Co Ltd
      • N4 Pharma Plc
        • Table Hypertension – Pipeline by N4 Pharma Plc
      • Nippon Shinyaku Co Ltd
        • Table Hypertension – Pipeline by Nippon Shinyaku Co Ltd
      • Nissan Chemical Industries Ltd
        • Table Hypertension – Pipeline by Nissan Chemical Industries Ltd
      • Northern Therapeutics Inc
        • Table Hypertension – Pipeline by Northern Therapeutics Inc
      • Novartis AG
        • Table Hypertension – Pipeline by Novartis AG
      • Omeros Corp
        • Table Hypertension – Pipeline by Omeros Corp
      • Orion Corporation
        • Table Hypertension – Pipeline by Orion Corporation
      • Peloton Therapeutics Inc
        • Table Hypertension – Pipeline by Peloton Therapeutics Inc
      • Pfizer Inc
        • Table Hypertension – Pipeline by Pfizer Inc
      • PhaseBio Pharmaceuticals Inc
        • Table Hypertension – Pipeline by PhaseBio Pharmaceuticals Inc
      • Pulmokine Inc
        • Table Hypertension – Pipeline by Pulmokine Inc
      • Quantum Genomics SA
        • Table Hypertension – Pipeline by Quantum Genomics SA
      • Reata Pharmaceuticals Inc
        • Table Hypertension – Pipeline by Reata Pharmaceuticals Inc
      • Relief Therapeutics Holding AG
        • Table Hypertension – Pipeline by Relief Therapeutics Holding AG
      • Relypsa Inc
        • Table Hypertension – Pipeline by Relypsa Inc
      • Renova Therapeutics Inc
        • Table Hypertension – Pipeline by Renova Therapeutics Inc
      • Respira Therapeutics Inc
        • Table Hypertension – Pipeline by Respira Therapeutics Inc
      • Reviva Pharmaceuticals Inc
        • Table Hypertension – Pipeline by Reviva Pharmaceuticals Inc
      • rEVO Biologics Inc
        • Table Hypertension – Pipeline by rEVO Biologics Inc
      • Roivant Sciences Ltd
        • Table Hypertension – Pipeline by Roivant Sciences Ltd
      • Rottapharm Biotech Srl
        • Table Hypertension – Pipeline by Rottapharm Biotech Srl
      • Sanofi
        • Table Hypertension – Pipeline by Sanofi
      • Sarfez Pharmaceuticals Inc
        • Table Hypertension – Pipeline by Sarfez Pharmaceuticals Inc
      • Serodus ASA
        • Table Hypertension – Pipeline by Serodus ASA
      • Shanghai Pharmaceutical Co Ltd
        • Table Hypertension – Pipeline by Shanghai Pharmaceutical Co Ltd
      • SJT Molecular Research SL
        • Table Hypertension – Pipeline by SJT Molecular Research SL
      • SteadyMed Therapeutics Inc
        • Table Hypertension – Pipeline by SteadyMed Therapeutics Inc
      • Suda Pharmaceuticals Ltd
        • Table Hypertension – Pipeline by Suda Pharmaceuticals Ltd
      • Sumitomo Dainippon Pharma Co Ltd
        • Table Hypertension – Pipeline by Sumitomo Dainippon Pharma Co Ltd
      • Sun Pharma Advanced Research Company Ltd
        • Table Hypertension – Pipeline by Sun Pharma Advanced Research Company Ltd
      • Takeda Pharmaceutical Co Ltd
        • Table Hypertension – Pipeline by Takeda Pharmaceutical Co Ltd
      • Target Medicals LLC
        • Table Hypertension – Pipeline by Target Medicals LLC
      • The Medicines Company
        • Table Hypertension – Pipeline by The Medicines Company
      • Theracos Inc
        • Table Hypertension – Pipeline by Theracos Inc
      • Theravance Biopharma Inc
        • Table Hypertension – Pipeline by Theravance Biopharma Inc
      • Toray Industries Inc
        • Table Hypertension – Pipeline by Toray Industries Inc
      • United Therapeutics Corp
        • Table Hypertension – Pipeline by United Therapeutics Corp
      • Vascular BioSciences
        • Table Hypertension – Pipeline by Vascular BioSciences
      • VG Life Sciences Inc
        • Table Hypertension – Pipeline by VG Life Sciences Inc
      • Vicore Pharma AB
        • Table Hypertension – Pipeline by Vicore Pharma AB
      • Vivus Inc
        • Table Hypertension – Pipeline by Vivus Inc
      • XuanZhu Pharma Co Ltd
        • Table Hypertension – Pipeline by XuanZhu Pharma Co Ltd
      • Yuhan Corp
        • Table Hypertension – Pipeline by Yuhan Corp
    • Hypotension
      • BCO Pharma Ltd
        • Table Hypotension – Pipeline by BCO Pharma Ltd
      • Cerecor Inc
        • Table Hypotension – Pipeline by Cerecor Inc
      • La Jolla Pharmaceutical Company
        • Table Hypotension – Pipeline by La Jolla Pharmaceutical Company
      • Theravance Biopharma Inc
        • Table Hypotension – Pipeline by Theravance Biopharma Inc
      • TrioxBio Inc
        • Table Hypotension – Pipeline by TrioxBio Inc
    • Pulmonary Arterial Hypertension
      • Acceleron Pharma Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Acceleron Pharma Inc
      • Actelion Pharmaceuticals Ltd
        • Table Pulmonary Arterial Hypertension – Pipeline by Actelion Pharmaceuticals Ltd
      • Aerogen Ltd
        • Table Pulmonary Arterial Hypertension – Pipeline by Aerogen Ltd
      • Arena Pharmaceuticals Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Arena Pharmaceuticals Inc
      • Ascendis Pharma A/S
        • Table Pulmonary Arterial Hypertension – Pipeline by Ascendis Pharma A/S
      • AVEO Pharmaceuticals Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by AVEO Pharmaceuticals Inc
      • Bayer AG
        • Table Pulmonary Arterial Hypertension – Pipeline by Bayer AG
      • Bial - Portela & Ca SA
        • Table Pulmonary Arterial Hypertension – Pipeline by Bial - Portela & Ca SA
      • Biogen Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Biogen Inc
      • Bristol-Myers Squibb Co
        • Table Pulmonary Arterial Hypertension – Pipeline by Bristol-Myers Squibb Co
      • Camurus AB
        • Table Pulmonary Arterial Hypertension – Pipeline by Camurus AB
      • Capricor Therapeutics Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Capricor Therapeutics Inc
      • Celsion Corp
        • Table Pulmonary Arterial Hypertension – Pipeline by Celsion Corp
      • Celtaxsys Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Celtaxsys Inc
      • Chiesi Farmaceutici SpA
        • Table Pulmonary Arterial Hypertension – Pipeline by Chiesi Farmaceutici SpA
      • Chugai Pharmaceutical Co Ltd
        • Table Pulmonary Arterial Hypertension – Pipeline by Chugai Pharmaceutical Co Ltd
      • Complexa Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Complexa Inc
      • Denovo Biopharma LLC
        • Table Pulmonary Arterial Hypertension – Pipeline by Denovo Biopharma LLC
      • Eli Lilly and Co
        • Table Pulmonary Arterial Hypertension – Pipeline by Eli Lilly and Co
      • Gilead Sciences Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Gilead Sciences Inc
      • GlaxoSmithKline Plc
        • Table Pulmonary Arterial Hypertension – Pipeline by GlaxoSmithKline Plc
      • Insmed Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Insmed Inc
      • Insys Therapeutics Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Insys Therapeutics Inc
      • Japan Tobacco Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Japan Tobacco Inc
      • Johnson & Johnson
        • Table Pulmonary Arterial Hypertension – Pipeline by Johnson & Johnson
      • Liquidia Technologies Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Liquidia Technologies Inc
      • MannKind Corp
        • Table Pulmonary Arterial Hypertension – Pipeline by MannKind Corp
      • Mezzion Pharma Co Ltd
        • Table Pulmonary Arterial Hypertension – Pipeline by Mezzion Pharma Co Ltd
      • Nippon Shinyaku Co Ltd
        • Table Pulmonary Arterial Hypertension – Pipeline by Nippon Shinyaku Co Ltd
      • Nissan Chemical Industries Ltd
        • Table Pulmonary Arterial Hypertension – Pipeline by Nissan Chemical Industries Ltd
      • Northern Therapeutics Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Northern Therapeutics Inc
      • Novartis AG
        • Table Pulmonary Arterial Hypertension – Pipeline by Novartis AG
      • Peloton Therapeutics Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Peloton Therapeutics Inc
      • PhaseBio Pharmaceuticals Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by PhaseBio Pharmaceuticals Inc
      • Pulmokine Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Pulmokine Inc
      • Reata Pharmaceuticals Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Reata Pharmaceuticals Inc
      • Relief Therapeutics Holding AG
        • Table Pulmonary Arterial Hypertension – Pipeline by Relief Therapeutics Holding AG
      • Respira Therapeutics Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Respira Therapeutics Inc
      • Reviva Pharmaceuticals Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Reviva Pharmaceuticals Inc
      • Roivant Sciences Ltd
        • Table Pulmonary Arterial Hypertension – Pipeline by Roivant Sciences Ltd
      • Serodus ASA
        • Table Pulmonary Arterial Hypertension – Pipeline by Serodus ASA
      • SteadyMed Therapeutics Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by SteadyMed Therapeutics Inc
      • Suda Pharmaceuticals Ltd
        • Table Pulmonary Arterial Hypertension – Pipeline by Suda Pharmaceuticals Ltd
      • Takeda Pharmaceutical Co Ltd
        • Table Pulmonary Arterial Hypertension – Pipeline by Takeda Pharmaceutical Co Ltd
      • Toray Industries Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Toray Industries Inc
      • United Therapeutics Corp
        • Table Pulmonary Arterial Hypertension – Pipeline by United Therapeutics Corp
      • Vicore Pharma AB
        • Table Pulmonary Arterial Hypertension – Pipeline by Vicore Pharma AB
      • Vivus Inc
        • Table Pulmonary Arterial Hypertension – Pipeline by Vivus Inc
  • Dormant Projects
    • Hypertension
      • Table Hypertension – Dormant Projects
    • Hypotension
      • Table Hypotension – Dormant Projects
    • Pulmonary Arterial Hypertension
      • Table Pulmonary Arterial Hypertension – Dormant Projects
  • Discontinued Products
    • Hypertension
      • Table Hypertension – Discontinued Products
    • Pulmonary Arterial Hypertension
      • Table Pulmonary Arterial Hypertension – Discontinued Products
  • Product Development Milestones
    • Hypertension
      • Featured News & Press Releases
    • Hypotension
      • Featured News & Press Releases
    • Pulmonary Arterial Hypertension
      • Featured News & Press Releases
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report